In another study, CSO was shown to increase the binding of the NF-κB p65 subunit to the promoter regions of IL-2- and Bcl-2-encoding genes in tumor-bearing mice (Huang X. et al., 2014). The gene discussed is BCL2; the disease is craniosynostosis.